Xylem downgraded at UBS on concerns about stalled growth (XYL:NYSE)
Summary
UBS downgraded Xylem (XYL) to Neutral, cutting PT to $132 on project delays and slower demand through 2026.
Description
UBS downgraded Xylem (XYL) to Neutral, cutting PT to $132 on project delays and slower demand through 2026.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source